Table 177
Percent of patients with adverse drug events: anticoagulant-related low-molecular-weight heparin and Factor Xa, United States, 2005a |
Population group |
Percent |
SE |
Total |
|
6.98 |
0.35 |
Age |
Under 65 |
6.60 |
0.93 |
65-74 |
6.51 |
0.59 |
75-84 |
7.37 |
0.60 |
85 and over |
7.37 |
0.85 |
Gender |
Female |
7.13 |
0.46 |
Male |
7.19 |
0.55 |
Race |
White |
6.82 |
0.37 |
Black |
6.48 |
1.09 |
Other |
10.94 |
1.95 |
Diabetes |
Yes |
7.42 |
0.62 |
No |
6.76 |
0.42 |
Obesity |
Yes |
7.69 |
0.94 |
No |
6.86 |
0.38 |
Cerebrovascular disease |
Yes |
8.08 |
0.76 |
No |
6.63 |
0.39 |
CHF/pulmonary edema |
Yes |
7.89 |
0.62 |
No |
6.49 |
0.42 |
COPD |
Yes |
7.28 |
0.60 |
No |
6.82 |
0.43 |
Smoking |
Yes |
6.88 |
0.89 |
No |
7.00 |
0.38 |
Corticosteroids |
Yes |
7.55 |
1.21 |
No |
6.93 |
0.37 |
Coronary artery disease |
Yes |
8.37 |
0.55 |
No |
5.73 |
0.44 |
Renal disease |
Yes |
11.93 |
0.89 |
No |
5.31 |
0.36 |
a Data include Medicare beneficiaries discharged from January to December.
Key: CHF: congestive heart failure; COPD: chronic obstructive pulmonary disease; SE: standard error.
Source: Centers for Medicare & Medicaid Services, Medicare Patient Safety Monitoring System.